NanoXort LLC Profile last edited on: 1/15/24
CAGE: 86NR2
UEI: XEFGPVQ94B79
Business Identifier: MRI imaging contrast agent solution 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
540 Devall Drive Suite 101-1a02
Auburn, AL 36832
Auburn, AL 36832
| (646) 258-9152 |
| contact@nanoxort.com |
| www.nanoxort.com |
Location: Single
Congr. District: 03
County: Lee
Congr. District: 03
County: Lee
Public Profile
Spun out of research conducted at Georgia Tech and at Auburn University, Nanoxort develops MRI contrast agents. The firm's contrast agents allow physicians to make more accurate disease diagnoses and provide patients with more personalized and effective treatments. The contact agents produce brighter images for more accurate readings, where contrast agents are used in roughly one-third of MRI procedures to help improve the accuracy for conditions such as inflammatory and infectious diseases. The firm's solution reduces the toxicity of MRI contrast agents and enables fine control of the properties of magnetic nano materials.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2023 | 2 | NSF | $1,255,676 | |
| Project Title: Novel Size-Changing, Gadolinium-Free Contrast Agent for Magnetic Resonance Angiography | ||||
Key People / Management
Tareq Anani -- President and Co-founder
Allan David -- Co-Founder
Abhinav Sannidhi -- R&D Manager / Principal Investigator
Barry Yeh -- Co-founder / General Manager
Allan David -- Co-Founder
Abhinav Sannidhi -- R&D Manager / Principal Investigator
Barry Yeh -- Co-founder / General Manager
